Ralliant Corporation (NYSE:RAL) Receives $50.50 Average Target Price from Brokerages

Ralliant Corporation (NYSE:RAL) has earned a consensus recommendation of “Moderate Buy” from the twelve analysts that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $50.50.

Several research analysts have recently commented on RAL shares. Weiss Ratings lowered Ralliant from a “hold (c)” rating to a “sell (d)” rating in a report on Thursday, February 5th. Royal Bank Of Canada cut their price objective on Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a report on Friday, February 6th. Morgan Stanley reissued an “overweight” rating and set a $45.00 price objective on shares of Ralliant in a report on Friday, February 6th. Truist Financial cut their price objective on Ralliant from $62.00 to $49.00 and set a “buy” rating for the company in a report on Friday, February 6th. Finally, Zacks Research raised Ralliant from a “strong sell” rating to a “hold” rating in a report on Monday, April 13th.

Ralliant Trading Down 2.3%

Shares of RAL opened at $45.27 on Thursday. The business’s 50-day moving average price is $44.00 and its 200-day moving average price is $46.83. Ralliant has a twelve month low of $37.27 and a twelve month high of $57.02. The stock has a market cap of $5.06 billion and a PE ratio of 23.09. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.38.

Ralliant (NYSE:RAL) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. The company had revenue of $554.60 million for the quarter, compared to the consensus estimate of $543.04 million. The company’s revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS. On average, equities analysts forecast that Ralliant will post 2.37 EPS for the current fiscal year.

Ralliant Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 23rd. Stockholders of record on Monday, March 9th were issued a dividend of $0.05 per share. The ex-dividend date of this dividend was Monday, March 9th. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. Ralliant’s payout ratio is presently 10.20%.

Insider Activity at Ralliant

In other Ralliant news, Director Kevin E. Bryant acquired 1,250 shares of the business’s stock in a transaction dated Friday, February 6th. The stock was bought at an average price of $39.97 per share, with a total value of $49,962.50. Following the completion of the acquisition, the director owned 4,653 shares of the company’s stock, valued at $185,980.41. This trade represents a 36.73% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Karen M. Bick sold 5,485 shares of the business’s stock in a transaction dated Tuesday, March 3rd. The stock was sold at an average price of $45.00, for a total value of $246,825.00. Following the transaction, the senior vice president directly owned 46,756 shares of the company’s stock, valued at $2,104,020. The trade was a 10.50% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have bought 8,145 shares of company stock valued at $332,233 in the last ninety days.

Institutional Trading of Ralliant

Several hedge funds and other institutional investors have recently bought and sold shares of RAL. Viking Global Investors LP purchased a new stake in Ralliant in the second quarter worth approximately $257,200,000. State Street Corp purchased a new stake in Ralliant in the second quarter worth approximately $213,096,000. Millennium Management LLC boosted its stake in Ralliant by 172.4% in the fourth quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock worth $253,175,000 after buying an additional 3,147,660 shares in the last quarter. Norges Bank purchased a new stake in Ralliant in the fourth quarter worth approximately $124,687,000. Finally, Invesco Ltd. boosted its stake in Ralliant by 90.1% in the third quarter. Invesco Ltd. now owns 3,871,690 shares of the company’s stock worth $169,309,000 after buying an additional 1,835,128 shares in the last quarter.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.